SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (1821)9/13/2007 1:41:47 PM
From: rkrw  Read Replies (2) | Respond to of 2240
 
No PR from Medarex on the deal. Wonder what exactly this means for medx?

<<while Medarex (NASDAQ: MEDX - news) will receive full rights to Genmab's multiple disease programmes in oncology.>>